View Clinical Trial (Medical Research Study)
Lipoprotein Metabolism in Normal Volunteers and Hyperlipoproteinemic Patients
| City: |
|
Bethesda |
| State: |
|
Maryland |
| Zip Code: |
|
20892 |
| Conditions: |
|
Abetalipoproteinemia - Atherosclerosis - Healthy - Inborn Errors Lipid Metabolism |
| Purpose: |
|
Researchers plan to study the fat-rich particles, called lipoproteins, which circulate in
the blood. This study is designed to improve understanding of normal, as well as abnormal,
lipoprotein metabolism and the role it plays in the development of hardening of the arteries
(atherosclerosis).
Patients participating in this study will receive injections of lipoproteins or
apolipoproteins (the protein component of lipoproteins) that have been isolated and
purified. These lipoproteins will be labeled with small amounts of radioactive material and
sterilized before they are injected into the patient.
Patients participating in the study will be required to have blood samples taken, and
provide urine samples throughout the course of the study. In addition, patient will be
required to follow a specially formulated diet. Patients will be weighed throughout the
course of the study.
|
| Study Summary: |
|
We propose to investigate human in vivo lipoprotein metabolism using radiolabeled
apolipoproteins on plasma lipoproteins. Paired kinetic studies using dual-labeled iodinated
lipoproteins and apolipoproteins are performed in healthy volunteer controls with normal
lipids and subjects with dyslipidemia under controlled metabolic conditions. Studies are
designed to formulate metabolic pathways in patients with undefined genetic disorders of
lipid metabolism as well as in healthy volunteers to provide original insights into normal
and pathologic metabolic pathways. All kinetic data is computer analyzed to provide
quantitative data and facilitate direct comparison of multiple studies.
|
| Criteria: |
|
- INCLUSION CRITERIA:
Subjects with new and undefined dyslipidemia-particularly familial disorders with extreme
phenotypes.
Healthy normal volunteers - (18 years old or older) controls to investigate the formation
of HDL for prebeta HDL.
Euthyroid.
EXCLUSION CRITERIA:
Healthy control volunteers are initially screened for secondary causes of hyperlipidemia
and are excluded if they have any clinically significant laboratory abnormality (i.e.,
liver disease, disease, kidney disease, endocrine disease,), chronic medical problems
(i.e., hypertension, migraines, inflammatory bowel, hepatitis, HIV) or require any chronic
medications (i.e., acne, asthma).
The healthy control volunteers weight must fall within the current guidelines for ideal
body weight.
Pregnant women.
Unwilling to follow metabolic diet.
Allergic to iodine.
Unable to sign consent form.
|
| NCT ID: |
|
NCT00001154 |
| Primary Contact: |
|
Principal Investigator
Robert D Shamburek, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Robert D Shamburek, M.D.
Phone: (301) 496-1500
Email: bob@mdb.nhlbi.nih.gov
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Bethesda, Maryland 20892
United States
For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL)
Phone: 800-411-1222
Email: prpl@mail.cc.nih.gov
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 21, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|